Treatment of febrile neutropenia: what is new?

Clicks: 328
ID: 115494
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Many of the identified points may have a great impact in the daily management of febrile granulocytopenic patients. However, all recent epidemiological and therapeutical studies underline the absoloute need for the knowledge of the pattern of infecting organisms in each center.
Reference Key
c2002currenttreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Viscoli C;Castagnola E;;
Journal current opinion in infectious diseases
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12130933
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine prognosis neoplasms / drug therapy bacteremia / drug therapy* antineoplastic agents / adverse effects fever / etiology* anti-bacterial agents / therapeutic use* neutropenia / etiology* pmid:12130933 doi:10.1097/00001432-200208000-00004 claudio viscoli elio castagnola bacteremia / physiopathology bone marrow transplantation / adverse effects* gram-positive bacterial infections / drug therapy* gram-positive bacterial infections / physiopathology neoplasms / physiopathology postoperative complications / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.